|
Dear Colleague,
We invite you to join us at the 6th CNS Partnering and Deal Making Conference
on September 9-10, 2013 in
Boston, MA to discuss strategies and best partnering models for
CNS-related discovery.
Over the past years, this
partnering and business development conference has given global biotechnology
and pharmaceutical companies an opportunity to network with high-level
executives from top pharma and various biotech/pharmaceutical companies, as well
as explore potential collaborations, and learn about relevant CNS disease issues
that will affect the industry.
However, with the unmet need for CNS
treatments growing, it is time to reevaluate how we partner with other
stakeholders in the field to accelerate research. We will discuss research
consortia, collaborations between academic centers and industry, and the
growing role of patient groups and foundations. This meeting creates a space for
leaders in the field to gather and invest in partnerships that will accelerate
research and move the field forward.
An
overview of the agenda:
I. Licensing and Partnering Strategies
II. Recent Advances in CNS Development
Panel:
Current and Future Trends in CNS
Development
Panel: Partnering in the AD, PD and
other Cognitive Disorders. How Have Things Changed?
Panel: Investment Opportunities with
Venture Capital
Panel: The Role of Foundations and Patient Groups in Research
To view this year’s agenda, click here.
To view this year's speaker list, click here.
This conference is a part of the larger
CNS Diseases World Summit 2013,
which also
includes the 7th
Neurodegenerative Conditions Research & Development
Conference.
We encourage you to sign
up for
a summit pass to get access to both conferences in the summit!
We
hope you’ll join us in Boston for what is sure to be a worthwhile meeting!
Best regards,
The 2013 Advisory Committee
|
